The power and pitfalls of omics part 2: epigenomics, transcriptomics and ME/CFS
Simon McGrath concludes his blog about the remarkable Prof George Davey Smith's smart ideas for understanding diseases, which may soon be applied to ME/CFS.
Discuss the article on the Forums.

Curza Aims At Treatment For Lyme Disease With New Antibiotic

Discussion in 'Lyme Disease and Co-Infections' started by shannah, Aug 29, 2015.

  1. shannah

    shannah Senior Member

    From Rick Laferriere

    Utah drug research company, Curza, takes aim at Lyme disease By Chris Miller, KUTV-TV, Salt Lake City, Utah

    August 25, 2015

    Curza, a Provo-based pharmaceutical research company, is on the cusp of a medical breakthrough that could treat victims of chronic Lyme disease.

    The company is entering phase two of clinical research on their newly designed antibiotic called CZ-99. They'll soon be testing the drug on infected mice at the University of California, Davis.

    An initial clinical trial at the University of New Haven in Connecticut, found CZ-99 to be 60 percent more effective in treating Lyme disease than the traditional antibiotics used to treat the illness.

    Curza CEO Ryan Davies says they have a patent on a technology used to penetrate bacteria's protective outer layer, or biofilm, making its new antibiotic more effective than outdated medications.
    adreno likes this.

See more popular forum discussions.

Share This Page